Investigation of rational use and regulation of traditional chinese medicine injections based on the utility analysis of our hospital from 2012 to 2014 / 中国药学杂志

ABSTRACT

OBJECTIVE: To discuss the methods for clinical rational use and state regulation of high risk Traditional Chinese Medicine Injections (TCMIs) based on our hospital TCMIs analysis and literature review. METHODS: By analyzing the prescription rates and amount percentage of TCMIs in emergency, outpatient and inpatient departments of our hospital as well as literature searching to learn the current state and conditions of TCMIs. RESULTS: Utilities of TCMIs from 2012 to 2014 shows an elevated tendency with percentages of 1.19%, 1.34% and 1.40% respectively. Emergency, ENT and internal neurology departments oi outpatient are the top 3 on prescription rates and amount percentage. Inpatients' order rates of TCMIs are 0.79%, 0.80% and 0.79% respectively. Oncology (20%-26%), emergency (12%-14%) and internal neurology (10%-11%) departments are the top 3 amount rates in ordering TCMIs,however, the department of TCM only account for 4%-5%. The percentages of TMCIs amount vs. annual total drug amount during 2012-2014 are 2.10%, 2.07% and 2.14%, which is lower than literature reports. CONCLUSION: Not all the TCMIs use in our hospital are rational, mainly reflects in non-TCM doctors having used the most amount of TCMIs. Therefore, the TCM consultation policy should be established to support TCMI rational utility, TCMIs labels should be strictly regulated and the quality standards of TCMIs should be elevated to ensure the safety and effectiveness. All above efforts should be done to protect and develop TCMI, an innovation of TCM.